Literature DB >> 212197

The complete sequence of a unique RNA species synthesized by a DI particle of VSV.

M Schubert, J D Keene, R A Lazzarini, S U Emerson.   

Abstract

The 2S RNA synthesized in vitro by the RNA polymerase of a defective interfering (DI) particle of vesicular stomatitis virus was labeled at its 3' terminus with 32P-cytidine 3', 5' bisphosphate and RNA ligase. Analysis of the labeled RNA showed that it was a family of RNAs of different length but all sharing the same 5' terminal sequence. The largest labeled RNA was purified by gel electrophoresis, and the sequence of 41 of its 46 nucleotides was determined by rapid RNA sequencing methods. The assignment of the remaining 5 nucleotides was made on the basis of an analysis of one of the smaller RNAs and published data. A new approach in RNA sequencing based on the identification of 3' terminal nucleotides of rna fragments originally present in the DI product or generated during the ligation reaction confirmed most of the sequence. The complete sequence of this 46 nucleotide long plus-sense RNA is: ppACGAAGACCACAAAACCAGAUAAAAAA UAAAAACCACAAGAGGGUC-OH. This RNA anneals to the RNA of the DI particle from which it was synthesized, indicating that its synthesis is template-specified. At least the first 17 and possibly all of the nucleotides are also complementary to sequences at the 3' end of two other VSV DI particles which were derived independently and whose genomes differ significantly in length. These data suggest a common 3' terminal sequence among all VSV DI particles which contain part of the Lgene region of the parental genome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212197     DOI: 10.1016/0092-8674(78)90086-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  32 in total

1.  Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis.

Authors:  P K Weck; R R Wagner
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

2.  Persistent vesicular stomatitis virus infection mediates base substitutions in viral RNA termini.

Authors:  B L Semler; J J Holland
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

3.  Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus.

Authors:  D D Rao; A S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Internal genome deletions in two distinct classes of defective interfering particles of vesicular stomatitis virus.

Authors:  J Perrault; B L Semler
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

5.  Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved.

Authors:  J D Keene; M Schubert; R A Lazzarini
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

6.  Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA.

Authors:  M Schubert; J D Keene; R C Herman; R A Lazzarini
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

7.  Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding.

Authors:  B W Grinnell; R R Wagner
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

8.  Polycistronic vesicular stomatitis virus RNA transcripts.

Authors:  R C Herman; M Schubert; J D Keene; R A Lazzarini
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

9.  Synthesis in vitro of the full-length complement of defective-interfering particle RNA of vesicular stomatitis virus.

Authors:  P K Chanda; C Y Kang; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  RNA synthesis of vesicular stomatitis virus. X. Transcription and replication by defective interfering particles.

Authors:  D D Rao; A S Huang
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.